Anna VanDommelen, PharmD

Manager, Health Outcomes, Provider Partnerships & Clinical Programs-Quality Support
OptumRx

Poster(s):

• (88) Impact of a diabetes deprescribing detailing initiative among commercially insured members
  Wednesday, October 29, 2025